Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherCONTINUING EDUCATION

Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology*

Pieter L. Jager, Willem Vaalburg, Jan Pruim, Elisabeth G.E. de Vries, Karl-Josef Langen and D. Albertus Piers
Journal of Nuclear Medicine March 2001, 42 (3) 432-445;
Pieter L. Jager
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Vaalburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Pruim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth G.E. de Vries
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl-Josef Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Albertus Piers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 3 432-445
PubMed 
11337520

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online March 1, 2001.

Copyright & Usage 
© 2001

Author Information

  1. Pieter L. Jager,
  2. Willem Vaalburg,
  3. Jan Pruim,
  4. Elisabeth G.E. de Vries,
  5. Karl-Josef Langen and
  6. D. Albertus Piers
  1. Department of Nuclear Medicine, PET Center, and Department of Medical Oncology, University Hospital Groningen, Groningen, The Netherlands; and Institute of Medicine, Research Center Jülich, Jülich, Germany
View Full Text

Statistics from Altmetric.com

Cited By...

  • 481 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: March 2001 to April 2025

AbstractFullPdf
Mar 200185301194
Apr 20014417077
May 20011810481
Jun 2001145420
Jul 20016368
Aug 200194529
Sep 2001104143
Oct 2001105731
Nov 200176639
Dec 2001122820
Jan 200234427
Feb 2002115230
Mar 200253926
Apr 200224529
May 200244228
Jun 200212825
Jul 200273727
Aug 200265539
Sep 200273335
Oct 2002134849
Nov 200275240
Dec 200241819
Jan 200374036
Feb 2003143934
Mar 200386236
Apr 2003156135
May 200343426
Jun 200343222
Jul 2003126637
Aug 2003135033
Sep 2003204725
Oct 2003255836
Nov 2003277041
Dec 200383426
Jan 2004185128
Feb 2004277152
Mar 2004138340
Apr 2004158737
May 2004198633
Jun 2004247424
Jul 20045114738
Aug 20044812228
Sep 2004359045
Oct 20044110730
Nov 2004229824
Dec 2004368437
Jan 2005269836
Feb 20052613443
Mar 20051811858
Apr 20051070107
May 2005105021
Jun 2005155718
Jul 2005124415
Aug 2005259741
Sep 2005188744
Oct 2005118337
Nov 2005179549
Dec 2005157035
Jan 2006138139
Feb 2006187831
Mar 2006147130
Apr 2006134422
May 2006104623
Jun 2006112214
Jul 2006164223
Aug 2006133722
Sep 200684432
Oct 200623415
Nov 2006134031
Dec 2006104017
Jan 200794134
Feb 200753727
Mar 200763830
Apr 2007125929
May 200785050
Jun 2007153932
Jul 2007123823
Aug 200733825
Sep 200783924
Oct 2007110825
Nov 2007112927
Dec 2007113831
Jan 200893412
Feb 2008104130
Mar 200895744
Apr 2008134739
May 200873929
Jun 2008194838
Jul 2008164228
Aug 2008124529
Sep 2008113127
Oct 2008105231
Nov 2008134937
Dec 200863523
Jan 2009102923
Feb 2009133728
Mar 200984237
Apr 2009163030
May 200974335
Jun 200962525
Jul 2009225622
Aug 2009122919
Sep 200983620
Oct 2009143632
Nov 2009192523
Dec 2009242723
Jan 2010142337
Feb 2010132027
Mar 2010253940
Apr 2010144225
May 2010104425
Jun 2010203621
Jul 2010162233
Aug 2010154838
Sep 2010152637
Oct 2010204843
Nov 2010232326
Dec 2010122223
Jan 2011172647
Feb 2011202432
Mar 2011162426
Apr 2011133533
May 2011174222
Jun 2011492425
Jul 2011321836
Aug 2011332821
Sep 2011422129
Oct 2011323031
Nov 2011352529
Dec 2011312430
Jan 2012342627
Feb 2012233224
Mar 2012353528
Apr 2012626336
May 2012555348
Jun 2012395826
Jul 2012444434
Aug 2012674844
Sep 2012444818
Oct 2012373233
Nov 2012556357
Dec 2012394226
Jan 2013516145
Feb 2013574338
Mar 2013433133
Apr 2013444436
May 2013594350
Jun 2013412919
Jul 2013232032
Aug 2013391118
Sep 2013242133
Oct 2013302946
Nov 2013302341
Dec 2013214139
Jan 2014264237
Feb 2014294753
Mar 2014294761
Apr 2014232031
May 2014272525
Jun 2014312427
Jul 2014315235
Aug 2014293727
Sep 2014444834
Oct 2014233229
Nov 2014235132
Dec 2014212811
Jan 2015215129
Feb 2015824227
Mar 2015443015
Apr 2015304720
May 2015406120
Jun 201512359
Jul 2015103225
Aug 2015243515
Sep 2015323014
Oct 2015263126
Nov 2015323618
Dec 2015394422
Jan 2016433622
Feb 20161273940
Mar 2016513740
Apr 2016343712
May 2016234919
Jun 2016436538
Jul 2016284322
Aug 2016204317
Sep 2016294030
Oct 2016408330
Nov 2016378234
Dec 2016174511
Jan 2017236318
Feb 2017265016
Mar 2017315525
Apr 2017344010
May 2017316911
Jun 2017315315
Jul 2017324010
Aug 2017285417
Sep 2017205616
Oct 2017225911
Nov 2017266520
Dec 2017254615
Jan 2018204219
Feb 2018193210
Mar 2018324136
Apr 2018144915
May 2018295721
Jun 201821418
Jul 2018144613
Aug 201891811
Sep 201893328
Oct 201810449
Nov 201810625
Dec 2018144014
Jan 201918466
Feb 2019236315
Mar 2019329018
Apr 2019286814
May 2019134518
Jun 2019172525
Jul 2019253211
Aug 2019122910
Sep 2019165216
Oct 201966818
Nov 2019154323
Dec 2019103321
Jan 202012166
Feb 2020188330
Mar 2020173422
Apr 2020124223
May 2020197536
Jun 2020126037
Jul 2020173225
Aug 202034525
Sep 202084326
Oct 2020165425
Nov 202075021
Dec 2020112928
Jan 2021163813
Feb 202196027
Mar 2021133324
Apr 2021177939
May 2021104321
Jun 2021102723
Jul 202193728
Aug 202181824
Sep 2021123531
Oct 202174516
Nov 2021153616
Dec 2021143315
Jan 2022113914
Feb 2022114121
Mar 202212529
Apr 20227388
May 202264110
Jun 2022152512
Jul 20227189
Aug 20225329
Sep 20229795
Oct 2022108416
Nov 202273120
Dec 202294215
Jan 2023218310
Feb 20238469
Mar 2023157930
Apr 202393422
May 20236296
Jun 20237709
Jul 202375017
Aug 2023133412
Sep 2023135611
Oct 202375413
Nov 2023127213
Dec 20231210614
Jan 2024241167
Feb 202422749
Mar 2024115923
Apr 20241111316
May 2024137415
Jun 2024349250
Jul 20243111220
Aug 20241520216
Sep 20241216120
Oct 20241018821
Nov 20241314726
Dec 20243111016
Jan 20252116041
Feb 20252729017
Mar 20252534034
Apr 20252232124
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 3
March 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology*
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology*
Pieter L. Jager, Willem Vaalburg, Jan Pruim, Elisabeth G.E. de Vries, Karl-Josef Langen, D. Albertus Piers
Journal of Nuclear Medicine Mar 2001, 42 (3) 432-445;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology*
Pieter L. Jager, Willem Vaalburg, Jan Pruim, Elisabeth G.E. de Vries, Karl-Josef Langen, D. Albertus Piers
Journal of Nuclear Medicine Mar 2001, 42 (3) 432-445;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • AMINO ACID AND PROTEIN METABOLISM
    • PRECLINICAL DATA FOR RADIOLABELED AMINO ACIDS
    • CLINICAL APPLICATIONS
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Diagnostic value of PET with different radiotracers and MRI for recurrent glioma: a Bayesian network meta-analysis
  • Interaction of Halogenated Tyrosine/Phenylalanine Derivatives with Organic Anion Transporter 1 in the Renal Handling of Tumor Imaging Probes
  • Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine
  • The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway
  • Determination of an Optimal Pharmacokinetic Model of 18F-FET for Quantitative Applications in Rat Brain Tumors
  • Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs
  • Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study
  • Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
  • Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas
  • Boramino acid as a marker for amino acid transporters
  • Anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid: Physiologic Uptake Patterns, Incidental Findings, and Variants That May Simulate Disease
  • First Clinical Results of (D)-18F-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non-Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma
  • Preclinical Characterization of 5-Amino-4-Oxo-[6-11C]Hexanoic Acid as an Imaging Probe to Estimate Protoporphyrin IX Accumulation Induced by Exogenous Aminolevulinic Acid
  • Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-Grade Glioma Patients
  • Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
  • A Meta-Analysis on the Diagnostic Performance of 18F-FDG and 11C-Methionine PET for Differentiating Brain Tumors
  • 11C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with 18F-FDG PET and Contrast Enhancement on MRI
  • Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents
  • Transport of 3-Fluoro-L-{alpha}-Methyl-Tyrosine by Tumor-Upregulated L-Type Amino Acid Transporter 1: A Cause of the Tumor Uptake in PET
  • Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
  • Impact of 3,4-Dihydroxy-6-18F-Fluoro-L-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
  • Evaluation of 4'-[Methyl-11C]Thiothymidine in a Rodent Tumor and Inflammation Model
  • Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications
  • O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
  • Putative Transport Mechanism and Intracellular Fate of Trans-1-Amino-3-18F-Fluorocyclobutanecarboxylic Acid in Human Prostate Cancer
  • S-11C-Methyl-L-Cysteine: A New Amino Acid PET Tracer for Cancer Imaging
  • Correlation of 6-18F-Fluoro-L-Dopa PET Uptake with Proliferation and Tumor Grade in Newly Diagnosed and Recurrent Gliomas
  • Efficacy of Systemic Radionuclide Therapy with p-131I-Iodo-L-Phenylalanine Combined with External Beam Photon Irradiation in Treating Malignant Gliomas
  • Methyl-L-11C-Methionine PET as a Diagnostic Marker for Malignant Progression in Patients with Glioma
  • Tumor Cell Metabolism Imaging
  • 6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications
  • L-Type Amino Acid Transporters LAT1 and LAT4 in Cancer: Uptake of 3-O-Methyl-6- 18F-Fluoro-L-Dopa in Human Adenocarcinoma and Squamous Cell Carcinoma In Vitro and In Vivo
  • Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases
  • 18F-FDOPA Kinetics in Brain Tumors
  • Clinical Applications of PET in Brain Tumors
  • Biodistribution and Radiation Dosimetry of the Synthetic Nonmetabolized Amino Acid Analogue Anti-18F-FACBC in Humans
  • PET/CT of Skull Base Meningiomas Using 2-18F-Fluoro-L-Tyrosine: Initial Report
  • Positron Emission Tomography As an Imaging Biomarker
  • 18F-FDOPA PET Imaging of Brain Tumors: Comparison Study with 18F-FDG PET and Evaluation of Diagnostic Accuracy
  • 18F-FET PET Differentiation of Ring-Enhancing Brain Lesions
  • Comparison of Sigma-Ligands and Metabolic PET Tracers for Differentiating Tumor from Inflammation
  • In Vivo Evaluation and Dosimetry of 123I-2-Iodo-D-Phenylalanine, a New Potential Tumor-Specific Tracer for SPECT, in an R1M Rhabdomyosarcoma Athymic Mouse Model
  • PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in Peripheral Tumors: First Clinical Results
  • In Vivo Characterization of 123/125I-2-Iodo-L-Phenylalanine in an R1M Rhabdomyosarcoma Athymic Mouse Model as a Potential Tumor Tracer for SPECT
  • 3-O-Methyl-6-18F-Fluoro-L-Dopa, a New Tumor Imaging Agent: Investigation of Transport Mechanism In Vitro
  • Prediction of Survival and Therapy Outcome with 11C-Tyrosine PET in Patients with Laryngeal Carcinoma
  • Delineation of Brain Tumor Extent with [11C]L-Methionine Positron Emission Tomography: Local Comparison with Stereotactic Histopathology
  • Molecular Transport Mechanisms of Radiolabeled Amino Acids for PET and SPECT
  • Quantitation of Small-Animal 124I Activity Distributions Using a Clinical PET/CT Scanner
  • Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine PET and 3-123I-Iodo-{alpha}-Methyl-L-Tyrosine SPECT in Brain Tumors
  • 18F-FLT PET for Visualization of Laryngeal Cancer: Comparison with 18F-FDG PET
  • Comparative Biodistribution of Iodinated Amino Acids in Rats: Selection of the Optimal Analog for Oncologic Imaging Outside the Brain
  • Whole-Body Tumor Imaging Using PET and 2-18F-Fluoro-L-Tyrosine: Preliminary Evaluation and Comparison with 18F-FDG
  • Early Response to Chemotherapy in Hypopharyngeal Cancer: Assessment with 11C-Methionine PET, Correlation with Morphologic Response, and Clinical Outcome
  • An Artificial Amino Acid, 4-Iodo-L-meta-Tyrosine: Biodistribution and Excretion via Kidney
  • L-1-11C-Tyrosine PET in Patients with Laryngeal Carcinomas: Comparison of Standardized Uptake Value and Protein Synthesis Rate
  • Isoform Selectivity of 3-125I-Iodo-{alpha}-Methyl-L-Tyrosine Membrane Transport in Human L-Type Amino Acid Transporters
  • Improving Amino Acid Imaging: Hungry or Stuffed?
  • Increased Tumor Uptake of 3-123I-Iodo-L-{alpha}-Methyltyrosine After Preloading with Amino Acids: An In Vivo Animal Imaging Study
  • Google Scholar

More in this TOC Section

  • Approaches to Imaging Immune Activation Using PET
  • Large Language Models and Large Multimodal Models in Medical Imaging: A Primer for Physicians
  • Precision Oncology in Melanoma: Changing Practices
Show more Continuing Education

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire